» Articles » PMID: 7954357

1,25-dihydroxyvitamin D3 Receptors in Normal and Malignant Human Colorectal Tissues

Overview
Journal Cancer Lett
Specialty Oncology
Date 1994 Oct 28
PMID 7954357
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

1 alpha,25-Dihydroxyvitamin D3, (1,25(OH)2D3), the active metabolite of vitamin D3, has important physiological effects on growth and differentiation in a variety of malignant and non-malignant cell types. In order to better understand the significance of 1,25(OH)2D3 receptors (VDR) in human colorectal cancer, we determined the levels of VDR in paired samples (malignant and adjacent normal tissues) of 24 colorectal cancer bearing patients. Our results demonstrated differences in the relative abundance of VDR between normal and transformed tissues according to the localization of the tumor. While colonic tumors exhibited significantly higher VDR values than their normal counterparts, the contrary seemed to occur in the rectal tumors. In colonic tumors, we found significant correlations between VDR levels and the absence of node involvement or a low Astler-Coller stage. The increased VDR values in colonic tumors as compared with the normal adjacent tissues, may warrant, at least in this type of cancer, the action of 1,25(OH)2D3 or its non-calcemic analogs, to help induce cell differentiation and growth inhibition.

Citing Articles

Prediagnostic Circulating Concentrations of Vitamin D Binding Protein and Survival among Patients with Colorectal Cancer.

Yuan C, Song M, Zhang Y, Wolpin B, Meyerhardt J, Ogino S Cancer Epidemiol Biomarkers Prev. 2020; 29(11):2323-2331.

PMID: 32917664 PMC: 7641995. DOI: 10.1158/1055-9965.EPI-20-0291.


Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review).

Krasanakis T, Nikolouzakis T, Sgantzos M, Mariolis-Sapsakos T, Souglakos J, Spandidos D Oncol Rep. 2019; 42(6):2228-2244.

PMID: 31578582 PMC: 6826302. DOI: 10.3892/or.2019.7351.


Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance).

Yuan C, Sato K, Hollis B, Zhang S, Niedzwiecki D, Ou F Clin Cancer Res. 2019; 25(24):7497-7505.

PMID: 31548349 PMC: 6911644. DOI: 10.1158/1078-0432.CCR-19-0877.


Influence of genetic variation in the vitamin D pathway on plasma 25-hydroxyvitamin D levels and survival among patients with metastatic colorectal cancer.

Yuan C, Renfro L, Ambadwar P, Ou F, McLeod H, Innocenti F Cancer Causes Control. 2019; 30(7):757-765.

PMID: 31104167 PMC: 6639016. DOI: 10.1007/s10552-019-01183-1.


Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation.

Savoie M, Paciorek A, Zhang L, Van Blarigan E, Sommovilla N, Abrams D J Gastrointest Cancer. 2018; 50(4):769-779.

PMID: 30058032 PMC: 6650370. DOI: 10.1007/s12029-018-0147-7.